首页> 外文OA文献 >Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus
【2h】

Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus

机译:高致病性猿猴/人类免疫缺陷症的出现 在恒河猴中用抗CD8 mAb治疗的恒河猴病毒 非致病性病毒的原发感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although simian/human immunodeficiency virus (SHIV) strain DH12replicates to high titers and causes immunodeficiency in pig-tailedmacaques, virus loads measured in SHIVDH12-infected rhesusmonkeys are consistently 100-fold lower and none of 22 inoculatedanimals have developed disease. We previously reported that theadministration of anti-human CD8 mAb to rhesus macaques at the time ofprimary SHIVDH12 infection resulted in marked elevations ofvirus loads. One of the treated animals experienced rapid and profounddepletions of circulating CD4+ T lymphocytes. Although theCD4+ T cell number partially recovered, this monkeysubsequently suffered significant weight loss and was euthanized. Atissue culture virus stock derived from this animal, designatedSHIVDH12R, induced marked and rapid CD4+ cellloss after i.v. inoculation of rhesus monkeys. Retrospective analysesof clinical specimens, collected during the emergence ofSHIVDH12R indicated: (i) the input clonedSHIV remained the predominant virus during the first 5–7 months ofinfection; (ii) variants bearing only a few of theSHIVDH12R consensus changes first appeared 7 months afterthe administration of anti-CD8 mAb; (iii) high titers ofneutralizing antibody directed against the input SHIV were detected byweek 10 and persisted throughout the infection; and (iv)no neutralizing antibody against SHIVDH12R ever developed.
机译:尽管猿猴/人类免疫缺陷病毒(SHIV)株DH12复制高滴度并在猪尾猕猴中引起免疫缺陷,但在SHIVDH12感染的恒河猴中测得的病毒载量始终低100倍,并且22种接种动物中没有一种已发展为疾病。我们先前曾报道在原发性SHIVDH12感染时向恒河猴施加抗人CD8 mAb导致病毒载量明显升高。被治疗的动物之一经历了循环CD4 + T淋巴细胞的快速和深度消耗。尽管CD4 + T细胞数目部分恢复,但该猴子随后体重明显减轻并被安乐死。在静脉内注射后,源自该动物的组织培养病毒原种被命名为SHIVDH12R,诱导了明显且快速的CD4 +细胞损失。接种恒河猴。在SHIVDH12R出现期间收集的临床标本的回顾性分析表明:(i)在感染的前5-7个月中,输入克隆的SHIV仍然是主要病毒; (ii)在给予抗CD8 mAb的7个月后首次出现仅带有少量SHIVDH12R共有改变的变体; (iii)在第10周之前检测到针对输入SHIV的高滴度中和抗体,并在整个感染期间持续存在; (iv)从未开发出针对SHIVDH12R的中和抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号